These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9311477)
1. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK). Eur J Surg; 1997 Sep; 163(9):693-701. PubMed ID: 9311477 [TBL] [Abstract][Full Text] [Related]
2. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I; Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer]. Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480 [TBL] [Abstract][Full Text] [Related]
5. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients. Gal R; Sadikov E; Sulkes J; Klein B; Koren R Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649 [TBL] [Abstract][Full Text] [Related]
6. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer. Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241 [TBL] [Abstract][Full Text] [Related]
7. Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711 [TBL] [Abstract][Full Text] [Related]
8. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK). Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115 [TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of colorectal cancer. Kemeny N; Saltz L; Cohen A Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089 [TBL] [Abstract][Full Text] [Related]
11. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
12. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group]. Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A; Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427 [TBL] [Abstract][Full Text] [Related]
13. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer]. Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967 [TBL] [Abstract][Full Text] [Related]
14. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer]. Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253 [TBL] [Abstract][Full Text] [Related]
15. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases]. Zhang ZG; Song C; Wang H Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081 [TBL] [Abstract][Full Text] [Related]
16. [Impact of perioperative chemotherapy on prognosis of colorectal cancer: a report of 82 cases]. Gong ZJ; Ren JQ; Kong G; Qing DJ; Liu H; Liang YQ Ai Zheng; 2007 Dec; 26(12):1350-3. PubMed ID: 18076799 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival. Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]